• Je něco špatně v tomto záznamu ?

Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form

J. Karbanová, J. Laco, AM. Marzesco, P. Janich, M. Voborníková, J. Mokrý, CA. Fargeas, WB. Huttner, D. Corbeil,

. 2014 ; 9 (6) : e98927.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023346

Prominin-1 (CD133) is physiologically expressed at the apical membranes of secretory (serous and mucous) and duct cells of major salivary glands. We investigated its expression in various human salivary gland lesions using two distinct anti-prominin-1 monoclonal antibodies (80B258 and AC133) applied on paraffin-embedded sections and characterized its occurrence in saliva. The 80B258 epitope was extensively expressed in adenoid cystic carcinoma, in lesser extent in acinic cell carcinoma and pleomorphic adenoma, and rarely in mucoepidermoid carcinoma. The 80B258 immunoreactivity was predominately detected at the apical membrane of tumor cells showing acinar or intercalated duct cell differentiation, which lined duct- or cyst-like structures, and in luminal secretions. It was observed on the whole cell membrane in non-luminal structures present in the vicinity of thin-walled blood vessels and hemorrhagic areas in adenoid cystic carcinoma. Of note, AC133 labeled only a subset of 80B258-positive structures. In peritumoral salivary gland tissues as well as in obstructive sialadenitis, an up-regulation of prominin-1 (both 80B258 and AC133 immunoreactivities) was observed in intercalated duct cells. In most tissues, prominin-1 was partially co-expressed with two cancer markers: carcinoembryonic antigen (CEA) and mucin-1 (MUC1). Differential centrifugation of saliva followed by immunoblotting indicated that all three markers were released in association with small membrane vesicles. Immuno-isolated prominin-1-positive vesicles contained CEA and MUC1, but also exosome-related proteins CD63, flotillin-1, flotillin-2 and the adaptor protein syntenin-1. The latter protein was shown to interact with prominin-1 as demonstrated by its co-immunoisolation. A fraction of saliva-associated prominin-1 appeared to be ubiquitinated. Collectively, our findings bring new insights into the biochemistry and trafficking of prominin-1 as well as its immunohistochemical profile in certain types of salivary gland tumors and inflammatory diseases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023346
003      
CZ-PrNML
005      
20150709122839.0
007      
ta
008      
150709s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0098927 $2 doi
035    __
$a (PubMed)24911657
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Karbanová, Jana $u Tissue Engineering Laboratories, BIOTEC, Technische Universität Dresden, Dresden, Germany; Department of Histology and Embryology, Charles University in Prague Faculty of Medicine and University Hospital Hradec Králové, Prague, Czech Republic.
245    10
$a Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form / $c J. Karbanová, J. Laco, AM. Marzesco, P. Janich, M. Voborníková, J. Mokrý, CA. Fargeas, WB. Huttner, D. Corbeil,
520    9_
$a Prominin-1 (CD133) is physiologically expressed at the apical membranes of secretory (serous and mucous) and duct cells of major salivary glands. We investigated its expression in various human salivary gland lesions using two distinct anti-prominin-1 monoclonal antibodies (80B258 and AC133) applied on paraffin-embedded sections and characterized its occurrence in saliva. The 80B258 epitope was extensively expressed in adenoid cystic carcinoma, in lesser extent in acinic cell carcinoma and pleomorphic adenoma, and rarely in mucoepidermoid carcinoma. The 80B258 immunoreactivity was predominately detected at the apical membrane of tumor cells showing acinar or intercalated duct cell differentiation, which lined duct- or cyst-like structures, and in luminal secretions. It was observed on the whole cell membrane in non-luminal structures present in the vicinity of thin-walled blood vessels and hemorrhagic areas in adenoid cystic carcinoma. Of note, AC133 labeled only a subset of 80B258-positive structures. In peritumoral salivary gland tissues as well as in obstructive sialadenitis, an up-regulation of prominin-1 (both 80B258 and AC133 immunoreactivities) was observed in intercalated duct cells. In most tissues, prominin-1 was partially co-expressed with two cancer markers: carcinoembryonic antigen (CEA) and mucin-1 (MUC1). Differential centrifugation of saliva followed by immunoblotting indicated that all three markers were released in association with small membrane vesicles. Immuno-isolated prominin-1-positive vesicles contained CEA and MUC1, but also exosome-related proteins CD63, flotillin-1, flotillin-2 and the adaptor protein syntenin-1. The latter protein was shown to interact with prominin-1 as demonstrated by its co-immunoisolation. A fraction of saliva-associated prominin-1 appeared to be ubiquitinated. Collectively, our findings bring new insights into the biochemistry and trafficking of prominin-1 as well as its immunohistochemical profile in certain types of salivary gland tumors and inflammatory diseases.
650    _2
$a CD antigeny $x metabolismus $7 D015703
650    _2
$a karcinoembryonální antigen $x metabolismus $7 D002272
650    _2
$a buněčná membrána $x metabolismus $7 D002462
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a glykoproteiny $x metabolismus $x sekrece $7 D006023
650    _2
$a lidé $7 D006801
650    _2
$a mucin 1 $x metabolismus $7 D018396
650    _2
$a stupeň nádoru $7 D060787
650    _2
$a peptidy $x metabolismus $x sekrece $7 D010455
650    _2
$a sliny $x metabolismus $7 D012463
650    _2
$a nádory slinných žláz $x metabolismus $x patologie $7 D012468
650    _2
$a sialoadenitida $x metabolismus $x patologie $7 D012793
650    _2
$a synteniny $x metabolismus $7 D053676
650    12
$a ubikvitinace $7 D054875
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Laco, Jan $u The Fingerland Department of Pathology, Charles University in Prague Faculty of Medicine and University Hospital Hradec Králové, Prague, Czech Republic.
700    1_
$a Marzesco, Anne-Marie $u Max-Planck-Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
700    1_
$a Janich, Peggy $u Tissue Engineering Laboratories, BIOTEC, Technische Universität Dresden, Dresden, Germany.
700    1_
$a Voborníková, Magda $u Department of Histology and Embryology, Charles University in Prague Faculty of Medicine and University Hospital Hradec Králové, Prague, Czech Republic.
700    1_
$a Mokrý, Jaroslav $u Department of Histology and Embryology, Charles University in Prague Faculty of Medicine and University Hospital Hradec Králové, Prague, Czech Republic.
700    1_
$a Fargeas, Christine A $u Tissue Engineering Laboratories, BIOTEC, Technische Universität Dresden, Dresden, Germany.
700    1_
$a Huttner, Wieland B $u Max-Planck-Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
700    1_
$a Corbeil, Denis $u Tissue Engineering Laboratories, BIOTEC, Technische Universität Dresden, Dresden, Germany.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 9, č. 6 (2014), s. e98927
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24911657 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150709122859 $b ABA008
999    __
$a ok $b bmc $g 1083684 $s 906339
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 9 $c 6 $d e98927 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Možnosti archivace